Recently, the Zhengzhou Municipal Bureau of Industry and Information Technology announced the list of Zhengzhou Enterprise Technology Centers for 2023, and Zhengzhou Hehe Bioengineering Technology Co., Ltd. was successfully recognized as the "Zhengzhou Enterprise Technology Center".
Probioway / H&H Bioengineering is a national high-tech enterprise focusing on the research development and industrialization of functional strains in the field of gastrointestinal microecological health. It has preserved more than 7,000 advantageous probiotic strains with independent intellectual property rights, of which 72 strains have achieved industrialization. Production, a total of 30 Chinese patents have been applied for, and 17 have been authorized, forming a product line with Lactobacillus casei PB-LC39, Lactobacillus rhamnosus PB-LR76, Lactobacillus reuteri PB-LR09, Lactobacillus johnsonii LBJ 456, plant milk Bacillus N-1 and other functional patent strains as the core of the full-scenario probiotic application solution have broken the monopoly of international industry giants on functional strains in terms of core technology and stability.
This recognition is an all-around recognition of Hehe Biotech’s innovation capabilities, innovative talents, technology accumulation, and R&D investment. In the future, Hehe Biotech will continue to improve its independent innovation capabilities, breakthrough key core technical issues in the fields of functional strain mining, high-density fermentation, and full-scenario application solutions for probiotics, and promote the development of my country's comprehensive health industry.